Asie · Bourse & Finance · Vietnam Investment Review

Translumina launches SPARX global trial for drug-coated coronary balloons

Publié par Vietnam Investment Review · Vietnam il y a 11 h

Medical device company Translumina initiated the multinational SPARX randomized controlled trial to evaluate drug-coated balloon treatment strategies against conventional…

Lire l'article complet sur Vietnam Investment Review Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (vir.com.vn)

Translumina launches SPARX global trial for drug-coated coronary balloons

À lire aussi

Capital goods stocks fall after multibagger rally. Is this a buying opportunity for long-term investors?

Let rupee find its own level: Uday Kotak

Google เปิดตัวโมเดล AI เรือธง “Gemini 4 Argon” สู่มือนักพัฒนา-ภาคธุรกิจทั่วโลก เร่งทวงความได้เปรียบจาก OpenAI-Anthropic

‘Brutal session’ for chip stocks shows AI trade is turning

IMDA expands digital support for SMEs

BOJ to lean against back-to-back rate hike in October — Bloomberg

Translumina launches SPARX global trial for drug-coated coronary balloons

Partager

À lire aussi

Capital goods stocks fall after multibagger rally. Is this a buying opportunity for long-term investors?

Let rupee find its own level: Uday Kotak

Google เปิดตัวโมเดล AI เรือธง “Gemini 4 Argon” สู่มือนักพัฒนา-ภาคธุรกิจทั่วโลก เร่งทวงความได้เปรียบจาก OpenAI-Anthropic

‘Brutal session’ for chip stocks shows AI trade is turning

IMDA expands digital support for SMEs

BOJ to lean against back-to-back rate hike in October — Bloomberg